| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.01 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |